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Abstract 
Objectives This study aims to perform a comprehensive review and study of diagnostic 
accuracy of BAEPs during MVD to predict hearing loss in studies published from January 
1984 to December 2013. 
 
Methods The PubMed/MEDLINE and World Science databases were searched. Studies 
performed MVD for trigeminal neuralgia, hemifacial spasm, glossopharyngeal neuralgia or 
geniculate neuralgia and monitored intraoperative BAEPs to prevent hearing loss. 
Retrospectively, BAEP parameters were compared with postoperative hearing. The 
diagnostic accuracy of significant change in BAEPs, which includes loss of response, was 
tested using summary receiver operative curve and diagnostic odds ratio (DOR). 
 
Results A total of 13 studies were included in the analysis with a total of 2,540 cases. Loss 
of response pooled sensitivity, specificity, and DOR with 95% confidence interval being 
74% (60–84%), 98% (88–100%), and 69.3 (18.2–263%), respectively. The similar 
significant change results were 88% (77–94%), 63% (40–81%), and 9.1 (3.9–21.6%). 
 
Conclusion Patients with hearing loss after MVD are more likely to have shown loss of 
BAEP responses intraoperatively. Loss of responses has high specificity in evaluating 
hearing loss. Patients undergoing MVD should have BAEP monitoring to prevent hearing 
loss. 
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Introduction 
Microvascular decompression (MVD) successfully treats trigeminal neuralgia (TGN), hemifacial 
spasm (HFS),  glossopharyngeal neuralgia (GPN) and geniculate neuralgia (GN) by relieving 
vascular compression on the cranial nerve (CN) at the root exit zone (RExZ) at CN III, CN V, 
CN IX and nervous intermedius in TGN, HFS, GPN and GN respectively[1-3]. Damage to CN 
VIII by retraction at the cerebellopontine angle or brainstem ischemia directly leads to post-
operative hearing loss[4]. The primary complication from surgery is hearing loss (HL) with a 
rate of 1-23.8%[2, 5-7]. Monitoring CN VIII utilizing intraoperative BAEPs has been shown to 
reduce post-operative CN VIII morbidity[8]. Clinical practice guidelines from the American 
Clinical Neurophysiology Society (ACNS) recommend alerting the surgeon at a significant 
threshold of change in the BAEPs. Significant changes are defined as a wave V latency increase 
≥1.0 ms and/or an amplitude decrease ≥50% [9, 10].   Although intraoperative monitoring with 
physician oversight remains the most effective method to prevent HL during MVD, it remains 
unclear when to alert the surgeon of CN VIII damage. Many studies have been performed to 
evaluate the usefulness of BAEPs during MVD for HFS, TGN, GPN. Our primary objective is to 
perform a comprehensive review of BAEP diagnostic accuracy during MVD to predict HL with 
attention to loss of the BAEP response and significant changes that might occur. The secondary 
objective is to investigate heterogeneity in the effectiveness of BAEPs for predicting HL 
amongst studies. 
Methods 
Criteria for considering studies for this review included randomized controlled trials, prospective 
or retrospective cohort reviews, which used BAEPs to indicate hearing loss during MVD. All 
studies report hearing outcomes, determined by pre and postoperative audiograms. When data or 
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subsets of data were presented in more than one study, the study with the most detailed data, or 
the study that was most recently published, was chosen. Excluded from this study are reviews, 
case reports, comments, editorials, and letters which did not report raw data. All studies with 
diagnosis of HL not directly related to MVD surgery were excluded. All studies have been 
published in English.  
Participants : 
All study participants were ≥18 years of age. Treatment of target conditions; TGN, HFS, GPN 
and GN that has become unmanageable or resistant to medication is referred for MVD. Patients 
underwent MVD in the period between January 1984 and December 2013. All studies performed 
intraoperative monitoring of BAEPs from the anesthesia to skin closure. No exclusion was given 
for the monitoring system used.  
Target conditions : 
MVD is used to treat vascular compression of cranial nerves. This study focuses on TGN, HFS, 
GPN and GN, but the majority of cases are either TGN or HFS in all studies. These disorders are 
caused by vascular compression at the root exit zone of the cranial nerves. HFS presents as tonic 
and clonic contractions of the muscles innervated by the facial nerve. TGN presents as intense 
pain on the ipsilateral side of the face. 
Reference Standards: 
Hearing loss was defined in several different ways among studies. One study used patient self-
reporting to classify hearing loss; in this case no hearing loss was reported. All other studies used 
pure tone audiometry and/or speech discrimination scores to determine HL. Audiometric testing 
was typically conducted by an audiologist. Testing occurred pre and post operatively within a 
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reasonable time period. Among studies that reported a cutoff value for hearing loss, the absolute 
value varied.   
Literature Search: 
A systematic literature search was performed through the PubMed/MEDLINE and World 
Science databases to identify articles on the diagnostic value of BAEPs for the detection of HL 
after MVDs. All the eligible studies were published through February 14, 2014. The following 
keywords were used: “auditory evoked response , auditory evoked potentials, brainstem auditory 
evoked potentials, brainstem auditory evoked response, Intraoperative monitoring,  or 
Intraoperative neurophysiological monitoring” and “microvascular decompression, or MVD” and 
“hemifacial spasm, HFS, trigeminal neuralgia, TGN,  tic douloureux, geniculate neuralgia, GN, 
nervus intermedius neuralgia, or glossopharyngeal neuralgia”. The list of articles was 
supplemented vie extensive cross-checking of the reference lists. There was no limitation on the 
sample size of the every single study. When there were multiple articles by the same group based 
on similar patients and using similar detection methods, only the largest or the most recent article 
was included. Our search criteria as well inclusion and exclusion criteria was optimized to 
minimize and prevent sources of bias common in observational studies[11].  
Data extraction and analysis: 
Two investigators (PDT, GCC) independently extracted relevant data on the design and results of 
each study using a standardized form. We extracted data from selected articles, which included 
first authors, year of publication, study population, region, diagnostic cut off point and time, and 
methods quality. The authors met and compared the articles each had excluded and reconciled 
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differences. A final list of articles that met the study inclusion criteria was assembled. Hearing 
loss after the procedure was the primary outcome recorded from the studies. The authors’ 
comprehensive data was included in the analysis, which was published in October 2014. 
We extracted data on the number of: True positives (TP), i.e. patients with hearing loss identified 
by both the reference and index tests; False negatives (FN), i.e. patients with hearing loss 
identified by the reference test, but as safe by the index test; True negatives (TN), i.e. patients 
without hearing loss confirmed by both the reference and index tests; False Positives (FP), i.e. 
patients without hearing loss confirmed by the reference test, but identified with hearing loss by 
the index test. 
The data was used to construct 2x2 tables. For each individual study, predictive value including 
sensitivity, specificity of changes in BAEPs to identify HL was calculated after categorizing 
patients into no change (NC), significant change (SC), transient loss (TL) and persistent loss 
(PL) based on changes in BAEPs during MVD.  BAEP waveform changes in latency and 
amplitude are dynamic during MVD, secondary to the degree of retraction and/or compression 
affecting the auditory nerve or its vasculature. Hence we felt that categorizing the changes which 
incorporated the current alarm criteria may be helpful in understanding the value of BAEPs 
during MVD.  Patients who experienced persistent wave V peak absolute latency increase ≥0.5 
ms and/or an amplitude reduction ≥ 50% and did not have loss of wave form during MVD were 
reported a significant change (SC). [9, 12] . Loss of waveform (LW) was defined as a wave V 
latency increase ≥12ms and/or 100% amplitude loss. The loss of Wave V of BAEP was further 
subdivided into persistent loss (PL) and transient loss (TL).  In transient loss (TL), patients’ wave 
V latency and amplitude returned to insignificant deviations from baseline by operative closure. 
In persistent loss, patients wave V remained at LW criteria by operative closure.  
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Assessment of methodological quality: 
The review authors used the QUADAS 2 tool to assess the susceptibility to bias of the included 
studies.  The methodological quality of the included studies was assessed independently by two 
review authors and disagreement was resolved by mutual consultation.  
Statistical analysis: 
We used Open Meta-Analyst and Stata 13 (metandi command) for the statistical analyses. The 
primary analysis of this review was to fit the data into a HSROC model using the bivariate 
model.(what does HSROC gives us and why HSROC, any citations).  We were also able to 
obtain pooled sensitivity and specificity through the same bivariate model used in generating the 
HSROC. For pooled estimates of diagnostic odds ratio (DOR), we used the Der-Simonian Laird 
random effects meta-analysis.  
We did not include datasets in the pooled analysis if either TP+FN = 0, or TN+FP  =0 because it 
was not possible to accurately estimate sensitivity or specificity. In other instance, we handled 
zero cell counts by adding a 0.5 continuity correction to the study data(citation). 
Heterogeneity:  
 Heterogeneity among included studies is assessed by using the Cochrane Q statistic and 
quantified with the I2 lying between 0 and 100%. In general, I2 (>50%) shows that heterogeneity 
among studies produce some impact, whereas I2 (<50%) shows that homogeneity is good for the 
reliability of meta-analysis.  
 
Results 
Results of the Search 
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The electronic search yielded a total of 121 records (Figure 1). We rejected 94 studies as they did 
not meet inclusion criteria. Of the two authors who screened the results, one author selected 25 
studies for potential inclusion and one author selected 40 studies. After disagreements were 
discussed between authors, we obtained the full-text copies of 27 studies. Of these, 14 studies 
were excluded for reasons stated in the flow diagram and 13 studies met the inclusion criteria for 
our review since they used an appropriate index and reference test in patients having MVD 
surgery.  
Figure 1. Results from searching studies for inclusion in the review 
 
 
Methodological quality of included studies 
Records identified through database searching  
(n = 121) 
Sc
re
e
n
in
g 
In
c
lu
d
e
d
 
E
li
g
ib
il
it
y
 
Id
e
n
ti
fi
ca
ti
o
n
 
Records screened  
(n =121) 
Records excluded  
(n = 94) 
Full-text articles assessed for 
eligibility  
(n = 27) Full-text articles excluded, 
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(n =14) 
Studies included in qualitative 
synthesis  
(n = 13) 
Studies included in meta-analysis  
(n = 13) 
56- BAEPS not used for IOM 
24- Editorials, case-reports, meta-analyses, or reviews 
4 –Did not Report Hearing Outcomes 
8- Subset of data presented in one article 
1- Study not published in English 
1- Study had no abstract 
3-Disagnosis of HL not related to MVD 
8-Not published in English 
1- Editorials, case-reports, meta-analyses, or reviews 
1-Did not use BAEPS to detect hearing loss 
1- Did not report Hearing outcomes 
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Methodological quality is presented in Figure 1. Characteristics of included studies are presented 
in Tables 2 and 3.  
Patient selection was unclear in one study due to unclear exclusions of patients, and high risk in 
one study due to non-random or consecutive sampling of patients. Seven out of thirteen studies 
had a high risk index test because they did not specify a threshold or cut-off value for significant 
changes, commonly referred to as alarm criteria. The reference standard risk of bias was unclear 
in three studies because no cut-off value was used to classify hearing loss. The risk was high in 
three studies, two were unlikely to correctly classify the target condition and one interpreted 
results of the reference standard with knowledge of the index test. Flow and timing had an 
unclear risk in two studies because the time interval between the index test and reference 
standard was not specified and a high risk in four studies. Three studies did not include all 
patients in their analysis and one did not give the reference standard to all patients. One study 
had a high applicability concern because some patients in the analysis did not undergo MVD. 
One study had a high applicability concern because not all patients received the index test. The 
reference standard applicability was unclear in two studies because hearing loss criteria was not 
reported as PTA or SDS scores. The reference standard applicability was of high concern in one 
study because patients subjectively requested auditory tests. 
Findings 
Total incidence of hearing loss in our study is 2.20%. Among patients who had no change in 
BAEPs, any changes, significant changes, loss of response, transient loss or permanent loss; the 
hearing loss rate was 0.46%, 7.96%, 2.32%, 5.21%, 24.00% and 49.30% respectively. Only 
Thirumala 2014 reported transient losses with hearing loss[13]. All studies used BAEPs to 
predict hearing loss intraoperatively. Alarm criteria were specified prior to surgery in 6 studies 
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and in the 7 others were determined during the course of study. Some studies were excluded 
from the statistical analysis because no patients experienced significant changes, or loss of 
response predictive of hearing loss. Only one study adopted the diagnostic accuracy paradigm in 
their analysis (Thirumala 2014) and the other studies reported outcomes to show how BAEPs 
may be interpreted. In the analysis, Loss of BAEP response and relationship to hearing loss, the 
excluded studies were Bond 2010, Huang 2009 and Radtke 1991. In the second analysis, Radtke 
1991 was added back.  
Loss of BAEP response and relationship to hearing loss (10 studies) 
Study sensitivities ranged from 50% to 90%, while specificities ranged from 44% to 100%. 
Combining data from all studies using the bivariate model, loss of BAEP response exhibited 
strong specificity (average [95% CI]: 98% [88%, 100%]) but weaker sensitivity (average [95% 
CI]: 74% [60%, 84%]). A graph of the estimated SROC along with the summary point, 95% 
confidence ellipse and prediction ellipse for BAEPs is shown in Figure 2. 
Figure 2 SROC of HL 
A. 
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B. 
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Figure 2. SROC for HL in (A) patients with loss of BAEP response and (B) patients with a 
significant change of BAEP response. The size of the study estimate circle indicates study effect 
size.  
 
 A pooled random effects estimate of diagnostic odds ratio for individual studies of 
patients with hearing loss with loss of BAEP response was 69.3 [18.2 - 263]. This indicates that 
the odds of observing loss of BAEP response among those with hearing loss are 69 times higher 
than those without hearing loss. Figure 3 shows a forest plot of diagnostic odds ratios (DOR) for 
the individual studies, with substantial heterogeneity of 63%.  
 
Figure 3. Forest Plots of HL 
A.  
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B.
 
Forest Plot for HL in (A) patients with loss of BAEP response and (B) patients with a significant 
change of BAEP response. CI= Confidence interval; TP= true positive; TN= true negative; FP= 
False Positive; FN = False Negative 
 
Loss of BAEP response or significant changes and their relationship with hearing loss (11 
studies) 
Study sensitivities ranged from 67% to 91%, while specificities ranged from 14% to 99%. 
Combining data from all studies using the bivariate model, loss of BAEP response or significant 
change exhibited strong specificity (average [95% CI]: 88% [77%, 94%]) but weaker sensitivity 
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(average [95% CI]: 63% [40%, 81%]). A graph of the estimated SROC along with the summary 
point, 95% confidence ellipse and prediction ellipse for BAEP is shown in Figure 2. 
 A pooled random effects estimate of diagnostic odds ratio for individual studies of 
patients with hearing loss with loss of BAEP response or significant change was 9.1 [3.9 – 21.6]. 
This indicates that the odds of observing loss of BAEP response or significant BAEP change 
among those with hearing loss are 9.1 times higher than those without hearing loss. Figure 3 
shows a forest plot of diagnostic odds ratios (DOR) for the individual studies, with mild-
moderate heterogeneity of 43%.  
Included in the appendix, patients with post-operative hearing loss or impairment have a 
7.79 higher DOR of losing BAEPs or having a significant change. The pooled sensitivity for 
these studies was improved compared to only hearing loss, but the specificity was lower. Hearing 
impairment was associated with loss of response at a DOR of 4.233. The sensitivity was below 
random and the specificity was high.  
 
Discussion 
Patients who experience peri operative loss of BAEP responses are 69 times more likely 
to experience HL. The pooled specificity across studies was high (98%) but the sensitivity was 
low (74%). The higher specificity of hearing loss in patients with BAEP loss indicates that, in 
some patients, recovery of BAEPs is desirable but not always achievable. The lower sensitivity 
could be secondary to the fact that when there is a loss of the response the surgical procedure is 
in most cases stopped until there is a recovery of the BAEP wave form. The therapeutic effect of 
surgical pause might have prevented hearing loss in many patients. Loss of BAEP response is 
often associated with unknown excessive stretch of CN VIII. Increasing the stretch of the axons 
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of CN VIII results in temporal dispersion of the wave forms resulting in a loss of amplitude[14]. 
If the stretch is prolonged, there is a risk for permanent injury. Loss of BAEP response can also 
be caused by changes in blood flow to the nerve, brain stem or direct trauma to the cranial nerve 
complex [15-18]. Loss of BAEP response can occur without loss of auditory function. This may 
result when be temporal dispersion without a conduction block in the auditory pathway or 
another hearing pathway not measured with BAEPs persists[19].Our analysis could not fully 
separate the patients who experience transient loss of BAEP responses with hearing loss, because 
many studies did not identify transient losses. Transient loss of response has a lower chance of 
hearing loss[13], compared to a permanent loss of response.  
Patients who experience peri operative significant changes are nine times more likely to 
experience hearing loss.  The sensitivity (63%) of significant changes is lower compared to the 
high specificity (88%). The strong specificity could be secondary to including patients with loss 
of BAEP responses in the analysis. Significant changes are meant to be an alarm during MVD so 
the surgeon can be aware of inadvertent auditory nerve stretch. The varied alarm criteria adopted 
in clinical practice may result in a weaker sensitivity and varied therapeutic inteventions.  The 
ACNS and ASNM recommend an alarm at a 1.0 ms or 10%, respectively, increase in latency of 
wave V and/or a decrease in the amplitude greater than 50%[9, 10]. The therapeutic effect of 
adjusting the retraction on the auditory nerve might be variable as the studies in this paper used 
multiple, different alarm criteria 
Overall incidence of hearing loss in our study was 2.20%. Hearing loss rates may vary by 
condition. Hearing loss has been evaluated using multiple criteria, with some using PTA alone 
and some using both PTA/SDS. Patients with any significant change in hearing were seven times 
more likely to experience significant change in BAEPs during the procedure. The clinical 
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relevance of the analysis is difficult to interpret as the hearing loss and hearing impairment are 
variably defined. The studies Jo 2011, Lee Jo 2013, Lee 2009, Ramnarayan 2006, Sindou 1992, 
and Radtke 1991 all reported PTA thresholds below 30 dB with an average of 20 dB. This 
hearing loss may be amenable to hearing aids and not as important in clinical practice. In 
addition the alarm criteria are varied among studies with different therapeutic interventions.  
Although the current study showed strengths based on comprehensive literature review, 
with quality assessment using the QUADA-2, there are several limitations that must be 
addressed. Most importantly, it is crucial to acknowledge the fact that a search bias may have 
existed owing to the difficulty associated with acquiring every possible study assessing use of 
BAEP during MVD. Also, owing to study design, our analysis is at risk of publication bias 
because of dependence on currently published data on the topic of investigation; however, our 
analysis via funnel plot (Supplementary Figure α) provides evidence of such bias in the current 
study. Statistically significant heterogeneity was observed among loss of response study 
specificity. Owing to the design of this study, it was difficult to assess every possible factor for 
such a result because of data pooling from diverse sources. 
Conclusion 
BAEPs are essential to preventing and predicting HL after MVD. Across all studies an increase 
in latency or decrease in amplitude increases the DOR for hearing loss. Despite 
recommendations from the ACNS/ASNM, significant changes are not universally defined. 
Without universal adoption, heterogeneity amongst studies and institutions will remain high. As 
loss of BAEPs during the procedure can be a specific marker of hearing loss allowing for 
perioperative intervention with novel treatment pathways directed to these patients. 
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 Table 1. Summary of Methodological Quality 
Study RISK OF BIAS APPLICABILITY CONCERNS 
PATIENT 
SELECTIO
N 
INDEX TEST REFERENCE 
STANDARD 
FLOW AND 
TIMING 
PATIENT 
SELECTION 
INDEX TEST REFERENCE 
STANDARD 
Bond, 2010 Low Low Unclear High Low Low Unclear 
Bricolo, 2004 Low Low Low Low Low Low Low 
Brock, 2004 Low High Low High Low Low Low 
Huang, 2009 Low High Unclear Unclear Low Low Unclear 
James, 2005 Low Low High High High Low Low 
Jo, 2011 Low Low Low Low Low Low Low 
Lee Jo, 2013 Low High Low Low Low Low Low 
Lee, 2009 Low High Low Low Low Low Low 
Ramnarayan, 
2006 
Low High Low Low Low Low Low 
Rizvi, 1999 Low High Unclear Unclear Low Low Low 
Radtke, 1991 Unclear High Low Low Low High High 
Sindou, 1992 High Low High High Low Low Low 
Thirumala, 
2014 
Low Low Low Low Low Low Low 
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Table 2. Study Profile and Characteristics. 
Author (pub yr) Study Design Condition Alarm Criteria HL Criteria Baseline BAEP Length of Follow-up 
Bond,2010 
Retrospective 
Cohort TGN 
Yes, transient 
changes of absolute 
or IPL in excess of 
10% baseline value 
 Self-reporting 
Yes (after 
anesthesia) Not Stated 
 
Bricolo,2004 
Retrospective 
Cohort HFS 
Yes, >0.5ms delay in 
the peak of Wave V, 
or if there were 
marked changes in 
amplitude or form of 
wave I or V 
Mild 26-40dB, 
Moderate 41-55, 
Intermediate 56-70, 
Severe 71-90, 
Profound >90 
Yes (after 
anesthesia) Before Discharge 
 
Brock 2004 
Retrospective 
Cohort TGN 
No, scores were 
considered abnormal 
if the abs. or IPL 
exceeded baseline 
by 2.5 standard 
deviations 
Slight 20-30dB, 
Moderate 35-40, 
Severe hypoacusia or 
anacusia 
Yes, (after 
anesthesia) Not Stated 
 
Huang,2009 
Retrospective cohort HFS No, >50% wave V 
amplitude decrease Not Stated 
Yes (after 
anesthesia) Not Stated 
 
James,2005 
Retrospective cohort HFS/TGN/CPA Surgery 
Yes, a 1.0 ms 
latency increase or 
50% amplitude 
decrease of wave V 
PTA cutoff 50 dB, 
SDS cutoff 50% 
Yes (after 
anesthesia) 
Immediately  Post-Op 
and upon discharge 
 
Jo,2011 
Retrospective cohort HFS 
Yes,   a 1.0 ms 
latency increase or 
50% amplitude 
decrease of wave V PTA cutoff 15 dB, 
SDS >20% 
Yes (before 
anesthesia) 3-10 days Post-Op 
 
Lee Jo,2013 
Retrospective 
Cohort HFS 
No, >0.5ms delay in 
the peak of Wave V, 
or if there were 
marked changes in 
amplitude or form of 
wave I or V 
PTA cutoff 15 dB, 
SDS >20% 
Yes (before 
anesthesia) 2-13 days Post-op 
 
Lee,2009 
Retrospective 
Cohort HFS 
No, 0.4ms (watch), 
0.6 ms (warn), 1.0 
ms (critical) wave V 
latency delay, and a 
50% amplitude 
reduction with a 
latency increase Cutoff >25 dB 
Yes (after 
anesthesia) 3-10 days Post-Op 
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Ramnarayan,2006 
Retrospective 
Cohort TGN 
No, greater than 3 
standard deviations 
over the normal 
mean value latency 
of wave V (4.77 + 
.23ms)  >20 dB 
Yes (after 
anesthesia) 48 Hours 
 
Rizvi,1999 
Retrospective 
Cohort TGN 
No, increase in IPL 
of 1.5 ms or an 
increase more than 3 
standard deviations 
No Cut Off Value, 
Given Distribution 
shows no major 
changes 
Yes (after 
anesthesia) N/A 
 
Radtke,1991 
Retrospective 
Cohort HFS,TGN 
No, wave V latency 
increase ≥1.0ms or 
rapid changes >0.1 
ms/min >30 dB 
Yes (before 
anesthesia) 
Immediately Post-Op 
and 1 month out 
 
Sindou,1992 
Retrospective 
Cohort HFS,TGN 
Yes, 1 ms in 10 
minutes or drastic 
modification, for 
voltage a decrease in 
amplitude of wave V 
>50% >20 dB 
Yes (after 
anesthesia) Immediately Post-Op 
 
Thirumala,2014 
Retrospective 
Cohort HFS,TGN,GN,GPN 
Yes, ,  a 1.0 ms 
latency increase or 
50% amplitude 
decrease of wave V <50% SDS. >50dB PTA 
Yes (after 
anesthesia) 1-90 Days Post Op 
 
Table 2. Study Profile and Characteristics. HFS= Hemifacial Spasm, TGN= trigeminal neuralgia, GN= geniculate neuralgia, GPN= glossopharyngeal 
neuralgia, SDS= Speech Discrimination Score, PTA= Pure Tone Audiometry.  IPL= interpeak latency 
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Table 3. Patient Demographics 
 
Author 
(pub, yr) 
Sample 
size for 
analysis 
Patient Age 
(Avg) 
Hearing Loss Hearing 
Impairment 
BAEP Changes  Significant 
Changes 
Transient 
Loss 
Permanent 
Loss 
Bond,2010 119 60 0 0 0 --- --- --- 
Bricolo,2004 84 53 1 8 8 3 2 3 
Brock, 2004 45 55.5 4 7 7 3 --- 4 
Huang,2009 36 N/A 0 1 0 --- --- --- 
James,2005 130 N/A 0 3 3 1 --- 2 
Jo,2011 1156 48.7 20 26 24 12 --- 12 
Lee Jo,2013 331 N/A 4 7 3 1 --- 2 
Lee,2009 22 61 1 2 3 2 --- 1 
Ramnarayan,2006 75 N/A 2 7 9 7 --- 2 
Rizvi,1999 9 N/A 1 3 4 3 --- 1 
Radtke,1991 261 53.9 0 9 6 2 3 1 
Sindou,1992 34 51 2 6 6 1 2 3 
Thirumala,2014 238 52.41 21 0 19 5 5 9 
Total 2540 51 56 79 92 40 12 40 
Table 3. Patient Demographics. A N/A indicates data was not collected on age. For BAEP changes, a line of --- indicates data was not recorded. 
Several studies did not comment on transient losses and their differnce from significant changes or permanent loss. In the studies Bond 2010 and 
Huang 2009, no change in BAEP was recorded and therefore there can be no discrimination between BAEP change categories.  
 
